InsidersTradesSigma
仁和药业 Stock: price and insider trades · China · SSE / SZSE (CSRC)
Track the 仁和药业 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 仁和药业 has published 9 insider filings. Market capitalisation: €7.9bn. The latest transaction was disclosed on 1 November 2023 (Purchase). Among the most active insiders: 杨潇. All data is free.
9
Insider Decl.
0
Thresholds
·
9 ops.
Buy Volume
·
0 ops.
Sell Volume
14Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 4,366 of 26,111 companies
68.9
score / 100
Value69
Quality69
FCF yld10%
Earn yld5.2%
EV/EBITDA9.7x
ROE6.6%
Gross mgn37%
Net mgn11%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 November 2023
Declarations9 total
9 of 9 declarations